BIOME AUSTRALIA LIMITED (BIO) - Revolutionizing Complementary Medicine: Founder Blair Vega Norfolk on Vision 27 Growth Plan, International Expansion, and Groundbreaking Probiotics

ASX BRIEFS

Send us a text

Curious about how clinical research can revolutionize the complementary medicine industry? On this episode of ASX Briefs, we sit down with Blair Vega Norfolk, the visionary Founder and Managing Director of Biome Australia. Blair's inspiring journey from struggling with autoimmune diseases to establishing Biome in 2018 underscores his commitment to science-driven product development over fleeting industry trends. Learn how Biome has rapidly ascended to success with their ambitious Vision 27 strategic plan, aiming for substantial revenue growth through innovative distribution and educational initiatives. Blair also unveils their groundbreaking Biome Cholesterol Probiotic, emphasizing the critical role of clinical data in maintaining their competitive edge.
Discover how Biome Australia is setting its sights on the global stage, with promising ventures in the UK, Ireland, Europe, and North America. Blair offers valuable insights into their lean and cost-effective approach to international expansion. Additionally, get a sneak peek into the promising results from clinical trials for products like Biome Lift, Biome Osteo, and Biome Kids. With potential benefits ranging from improved mood to reduced bone density loss, these innovations are poised to bolster Biome's credibility and market presence. Tune in for an in-depth look at how Biome Australia aims to revolutionize the complementary medicine industry through clinically proven products and strategic growth initiatives.

Chapitres

1. BIOME AUSTRALIA LIMITED (BIO) - Revolutionizing Complementary Medicine: Founder Blair Vega Norfolk on Vision 27 Growth Plan, International Expansion, and Groundbreaking Probiotics (00:00:00)

2. Biome Australia Growth and Innovation (00:00:02)

3. Biome International Expansion and Clinical Trials (00:05:56)